Three things to know:
1. NuCress is designed to promote bone regeneration in fractures, gaps where bone is missing and major injury defects.
2. The biomaterial’s bone regeneration potential would benefit a range of patients including wounded soldiers, people with bone diseases, victims of major accidents and trauma.
3. NuCress was developed at the UA Little Rock Center for Integrative Nanotechnology Sciences.
More articles on biologics:
19 spine devices receive FDA 510(k) clearance in October
Medtronic Q2 spine revenue up 5.5%
Orthofix M6-C cervical disc in 2019: 7 key developments
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
